A meeting for phase III clinical trial researchers for 18F-NaF injection was held successfully

2023-07-18

On September 30, 2020, a meeting for phase III clinical trial researchers for 18F-NaF injection was held successfully. The meeting is organized by Quarkmed and presided over by Huo Li, director of Nuclear Medicine Department, Peking Union Medical College Hospital. The injection is researched and developed by CNNC HTA Co., Ltd. Many distinguished guests from Peking Union Medical College Hospital, ...